NLTX - Neoleukin Therapeutics Inc. (NLTX) CEO Jonathan Drachman on Q4 2019 Results - Earnings Call Transcript
Neoleukin Therapeutics, Inc. (NLTX)
Q4 2019 Earnings Conference Call
March 12, 2020, 16:30 ET
Company Participants
Julie Rathbun - Communications
Jonathan Drachman - CEO, President & Interim Chairman
Kamran Alam - Interim CFO, VP, Finance & Corporate Secretary
Conference Call Participants
Tyler Van Buren - Piper Sandler & Co.
Charles Zhu - Guggenheim Securities
Arlinda Lee - Canaccord Genuity
Presentation
Operator
Good afternoon, and thank you for joining us today for the Neoleukin Therapeutics Conference Call. [Operator Instructions].
I will turn the call over to Julie Rathbun, Communications for Neoleukin Therapeutics. Julie, please go ahead.